This inventor holds 1 USPTO granted patent. Top assignee: Alcobra Ltd.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Jonathan Rubin - Innovator in Cognitive Disorder Therapies
Introduction
Jonathan Rubin is a notable inventor based in Newtown Square, PA (US). He has made significant contributions to the field of cognitive disorders through his innovative research and patenting efforts. His work primarily focuses on therapies aimed at improving the lives of individuals affected by conditions such as Fragile X Syndrome.
Latest Patents
Jonathan Rubin holds a patent titled "Methods of determining response to therapy." This invention relates to methods for determining the response to metadoxine therapy for the treatment of Fragile X Syndrome and other cognitive disorders. The patent also encompasses the identification of individuals who are likely to respond positively to metadoxine therapy. He has 1 patent to his name.
Career Highlights
Jonathan Rubin is associated with Alcobra Ltd., a company dedicated to developing innovative treatments for cognitive disorders. His role at the company has allowed him to contribute to groundbreaking research and therapeutic methods that aim to enhance patient outcomes.
Collaborations
Throughout his career, Jonathan has collaborated with esteemed colleagues such as Yaron Daniely and Johanna Schumann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in the field.
Conclusion
Jonathan Rubin's work in developing methods for determining therapy responses represents a significant advancement in the treatment of cognitive disorders. His contributions continue to impact the lives of many individuals, showcasing the importance of innovation in healthcare.